Harbour Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,925	Closed	-$405K	–	284
2024 Q3	$405K	Sell	8,925 -355	-4%	-$16.1K	0.09%	195
2024 Q2	$501K	Buy	9,280 +5,050	+119%	+$272K	0.12%	168
2024 Q1	$275K	Sell	4,230 -100	-2%	-$6.5K	0.07%	237
2023 Q4	$271K	Buy	+4,330	New	+$271K	0.07%	224